Patents Assigned to Valpharma S.A.

Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration

Patent number: 6994873

Abstract: This invention refers to: multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional release granules, suitable for once-a-day administration also at high strengths of Lithium salts, and to the preparation process of said formulations.

Type: Grant

Filed: February 4, 2002

Date of Patent: February 7, 2006

Assignee: Valpharma S.A.

Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards HIV sensitive strains and towards HIV strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitors

Publication number: 20040006103

Abstract: Use of at least one 4 amino-quinolinic derivative to obtain a drug for the anti-retroviral therapy, especially in the therapy of the HIV disease-infection caused by retroviral strains, which are sensitive and/or resistant to known therapies.

Type: Application

Filed: June 19, 2003

Publication date: January 8, 2004

Applicant: VALPHARMA S.A.

Inventors: Roberto Valducci, Taziano Alighieri, Serozh Avanessian
Multiparticulate enteric coated and multiparticulate enteric coated prolonged release formulations containing NADH

Publication number: 20030181414

Abstract: Formulations for the oral administration of NADH in multiparticulate enteric coated form and/or dosed either into gelatine capsules or sachets or dispensers

Type: Application

Filed: March 12, 2003

Publication date: September 25, 2003

Applicant: VALPHARMA S.A.

Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
Modified release pharmaceutical composition containing bupropion HCI as active substance

Publication number: 20030134906

Abstract: Pharmaceutical composition in modified release tablet form containing Bupropion HCl as active substance and including, at the same time, hydrophilic components and hydrophobic ingredients mixed with an excipient substance.

Type: Application

Filed: May 31, 2002

Publication date: July 17, 2003

Applicant: VALPHARMA S.A.

Inventors: Roberto Valducci, Tiziano Alighieri, Serozh Avanessian
Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance

Patent number: 5871775

Abstract: Controlled release pharmaceutical compositions for the oral administration of nifedipine are disclosed which comprise an amorphous coprecipitate of nifedipine and polyvinylpyrrolidone with suitable excipients. The release rate may be varied from 8 to 24 hours by varying the amounts of the cellulose derivative, the carboxypolymethylene and the lactose.

Type: Grant

Filed: September 9, 1997

Date of Patent: February 16, 1999

Assignee: Valpharma S.A.

Inventor: Roberto Valducci

Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration

Multiparticulate enteric coated and multiparticulate enteric coated prolonged release formulations containing NADH

Modified release pharmaceutical composition containing bupropion HCI as active substance

Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance